MONECO 400 FOR CATTLE, GOATS AND POULTRY

Country: Australia

Language: English

Source: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Active ingredient:

MONENSIN AS MONENSIN SODIUM

Available from:

INTERNATIONAL ANIMAL HEALTH PRODUCTS PTY LTD

INN (International Name):

monensin as sodium(400g/kg)

Pharmaceutical form:

ORAL POWDER, PRE-MIX

Composition:

MONENSIN AS MONENSIN SODIUM ANTIPROTOZOAL Active 400.0 g/kg

Units in package:

20kg; 25kg

Class:

VM - Veterinary Medicine

Manufactured by:

IAHP

Therapeutic area:

NUTRITION & METABOLISM

Product summary:

Poison schedule: 4; Withholding period: WITHHOLDING PERIODS: CATTLE: MEAT and MILK: Zero (0) days. GOATS: MEAT: Zero (0) days. MILK: DO NOT USE in goats pro ducing milk for human consumption. POU LTRY: MEAT: Zero (0) days. EGGS: DO NOT USE in birds which are producing eggs or may in future produce egg or egg pro ducts for human consumption. EXPORT S LAUGHTER INTERVAL (ESI): This product d oes not have an ESI established.; Host/pest details: CATTLE: [IMPROVE REPRODUCTIVE PERFORMANCE, PREVENTION OF COCCIDIOSIS, PRODUCTIVITY IMPROVEMENTS]; CATTLE - BEEF: [BLOAT, IMPROVE FEED EFFICIENCY]; DAIRY CATTLE: [BLOAT, IMPROVEMENT OF MILK PRODUCTION, KETOSIS]; GOAT: [PREVENTION OF COCCIDIOSIS]; POULTRY: [COCCIDIOSIS - SEE LABEL FOR CAUSES]; PULLET-LAYING REPLACEMENT: [COCCIDIOSIS - SEE LABEL FOR CAUSES]; For improved feed effiiciency (feedlot cattle), as an aid in the control of bloat (feedlot cattle & dairy cows), as an aid in the prevention of coccidiosis (cattle, goats & poultry), heifers & dairy cows - see label.See Restraints, Contraindications & Precautions on label

Authorization status:

Registered

Authorization date:

2023-07-01

Patient Information leaflet

APPENDIX2
TEMPLATE
FOR
RELEVANT
LABEL
PARTICULARS
(RLPs)
(Veterinary
Products)
Select appropriate:
·
~
New Product (include
all
applicable RLPs)
OR
CJ
Variation
(highlight
instructions
that
are
being
varied).
Approval
no.
of
label
being
varied:
................
.
Signal
heading:
Product
name:
Active
constituentls:
Statement
of
claims:
Net
contents:
Directions for Use
Heading:
Restraints:
Contraindications:
PRESCRIPTION
ANIMAL
REMEDY
KEEP
OUT
OF
REACH
OF
CHILDREN
READ
SAFETY
DIRECTIONS
BEFORE
OPENING
OR
USING
FOR
ANIMAL
Tl'!EATMENT
ONLY
MONECQ®4QO
A
Rl
FOR
CATTLE,
GOATS
AND
POULTl'!Y
ACTIVE
CONSTITUENT:
400
g/kg
MONENSIN
(as
monensin
sodium)
FEEDLOT
CATTLE:
For improved feed efficiency.
As
an aid in the control
of
bloat.
CATTLE:
As an aid in the prevention
of
coccidiosis caused
by
Eimeria Zuernii
and
Eimeria bovis.
For increased rate
of
weight gain and feed
efficiency in heifers.
For improved reproductive performance in heifers.
DAIRY
COWS:
For increased milk production
under
some
conditions.
As
an aid in reducing the severity
of
non-clinical
ketosis in lactating dairy cows.
As
an aid in the control
of
bloat.
GOATS:
As an aid in the prevention
of
coccidiosis.
POULTRY:
As an aid in
the
prevention
of
coccidiosis caused
(Broiler
and
by
Eimeria acervulina,
E.
brunetti,
E.
maxima,
E.
Replacement
Layers)
mivati,
E.
necatrix,
E.
tenella.
20 [25] kg
DIRECTIONS
FOR
USE:
DO
NOT
USE
in
goats
producing
milk
for
human
consumption.
DO
NOT
USE
in
birds
which
are
producing
eggs
or
may
in
future
produce
egg
or
egg
products
for
human
consumption.
The
recommended
levels
of
MONECO
400
High
levels
may
cause
decreased
feed
18
Wormald Street, Symonston ACT 2609
PO
Box
6182.
Kingston
ACT
2604
Australia
Tel:
+61
2
6210 4700
Fax:
+61
2
6210 4874
www.apvma.gov.au
ABN
19 495
043
447
must
not
be
exceeded.
poor
LL
diarrhoea
~p
"
Precautions:
Side effects:
Dosage
&
administration:
and death. Responses
to
MONECO 400 are
unlikely
if
nutrient
intake
is
severely
restricted. Horses,
other
equines
or
dogs
should
not
be
fed
or
allowed
access
to
feed